$14.160
+0.224 (+1.58%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy BlossomHill Therapeutics Inc Stock?
BlossomHill Therapeutics is a good buy right now due to its recent FDA Fast Track designation for BH-30643, which has shown a 45% objective response rate in clinical trials. Despite a current price of $13.94 and a significant 20.25% drop over the past five days, the potential upside indicated by analyst price targets of $40 suggests a strong recovery opportunity. The main risk is the negative net income of -23,758,000 USD reported in Q2 2026, which reflects ongoing financial challenges.
BLSM stock price ended at $14.16 on Monday, after rising +1.58%
BlossomHill Therapeutics Inc (BLSM) last closed at $14.16, gaining +1.58%. These facts feed the 1-day and 1-week BLSM price prediction above.
Forecast Drivers
BlossomHill Therapeutics Inc (BLSM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Seasonality analysis for BLSM
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.